Lin‐Hung Wei

ORCID: 0000-0001-8789-0859 · 3 papers in corpus
observational 2023
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14930

Synopsis Dienogest appears not to have any adverse breast effects on women of reproductive age.

2022
·doi:10.2139/ssrn.4128897
observational 2022
Journal of ovarian research ·doi:10.1186/s13048-022-01019-8

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is the most common endometriosis-associated ovarian cancer. Ovarian endometriosis may present with atypical or malignant sonographic features and interfere with clinical judgment about whether…